Prof Rose Hayeshi, associate professor from the NWU's Preclinical Drug Development Platform, at work with the new machine.
Machine masters medical breakthrough
The NWU's Preclinical Drug Development Platform (PCDDP) on the Potchefstroom Campus is now using cutting-edge technology to shorten patient recovery time and to accelerate new drug development.
The PCDDP recently acquired a machine that can fill hard gelatine capsules with liquid or gel and then seal them. This is dramatically changing the way the PCDDP works, as this machine considerably shortens the process of manufacturing new drugs.
According to Prof Anne Grobler, director of the platform, this technological breakthrough is a first for the African continent. “The NWU is one of very few universities worldwide with access to this technology.”
The CFS1200 machine was developed by the international company Capsugel and adapted for use in South Africa.
How it works
Prof Anne Grobler, director of the platform, says the multimillion-rand machine is now taking NWU scientists to new, previously impossible heights. With her is Dr Philippe Peter, project head of Capsugel.
Where does this machine come from?
At the forefront of drug development – the human body absorbs liquid more effectively. Using liquid forms to administer drugs increases the effectiveness of drugs and accelerates patient recovery.
Breakthrough builds on success
Click to read more